Showing results (591-600 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|October 14, 2005
Modelling and simulation in the development and use of anti-cancer agents: an underused tool?Ferdinand Rombout, Leon Aarons, Mats Karlsson, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 6, 2017
Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selectionYasunori Aoki, Daniel Röshammar, Bengt Hamrén, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 19, 2017
Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazoleAhmad Y Abuhelwa, Stuart Mudge, Richard N Upton, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 10, 2017
Comparison of tenofovir plasma and tissue exposure using a population pharmacokinetic model and bootstrap: a simulation study from observed dataJon W Collins, J Heyward Hull, Julie B DumondJournal of Pharmacokinetics and Pharmacodynamics|November 25, 2017
Lack of ethnic differences of moxifloxacin and metabolite pharmacokinetics in East Asian menM Kaneko, T Aoyama, Y Ishida, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 12, 2018
Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimensAurelia H M de Vries Schultink, Annelies H Boekhout, Jourik A Gietema, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 5, 2019
Application of new measures of nonlinearity to parameter estimation and simulations in individual pharmacokinetic analysesLeonid Khinkis, Milburn CrotzerJournal of Pharmacokinetics and Pharmacodynamics|December 16, 2018
Variance based global sensitivity analysis of physiologically based pharmacokinetic absorption models for BCS I-IV drugsNicola Melillo, Leon Aarons, Paolo Magni, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 18, 2018
A comprehensive evaluation of exposure-response relationships in clinical trials: application to support guselkumab dose selection for patients with psoriasisChuanpu Hu, Zhenling Yao, Yang Chen, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 21, 2018
Assessing QT/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methodsJingtao Lu, Jianguo Li, Gabriel Helmlinger, et al.Pageof 107